These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3260395)

  • 1. [Evaluation of acute and chronic cerebral ischemia in man by positron and single photon emission tomography: application to the study of duxil].
    Guez D
    Rev Med Interne; 1988 Feb; 9(1):33-9. PubMed ID: 3260395
    [No Abstract]   [Full Text] [Related]  

  • 2. [Evaluation of the therapeutic effect of duxil in chronic cerebral insufficiency. Analysis of 4636 patients at cerebrovascular risk].
    Mémin Y
    Rev Med Interne; 1988 Feb; 9(1):64-72. PubMed ID: 3387704
    [No Abstract]   [Full Text] [Related]  

  • 3. [Metabolic and blood circulation evaluation of acute ischemic cerebral accident in humans using positron emission tomography].
    Depresseux JC; Franck G; Van Cauwenberge H
    Presse Med; 1987 Jun; 16(23):1145-50. PubMed ID: 2885825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Experimental models in cerebral ischemia: application to the study of duxil].
    Labrid C
    Rev Med Interne; 1988 Feb; 9(1):21-6. PubMed ID: 3291037
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effects of 5023 SE on experimental cerebral ischemia in gerbils].
    Duhault J; Roman F; Dellazuana O; Actis H
    Presse Med; 1983 Mar; 12(13):844-6. PubMed ID: 6220333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic and circulatory evaluation of cerebral ischemic accident in humans by positron emission tomography: a pilot study with almitrine-raubasine.
    Depresseux JC; Franck G; Van Cauwenberge H; Cattelin F
    Clin Neuropharmacol; 1990; 13 Suppl 3():S40-9. PubMed ID: 2093417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebral ischemia: from pharmacology to modern techniques and clinical implications. Value of almitrine-raubasin (Duxil Duxaril). International symposium, Hangzhou, People's Republic of China, May 14, 1994.
    Eur Neurol; 1995; 35 Suppl 1():1-46. PubMed ID: 8529722
    [No Abstract]   [Full Text] [Related]  

  • 8. [Evaluation of the activity of duxil in the endocochlear hypoacusis of ischemic origin].
    Soubeyrand L; Bordes LR; Blondin P
    Rev Med Interne; 1988 Feb; 9(1):45-50. PubMed ID: 3387702
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pharmacological approach to a treatment of senescence and cerebrovascular deficiencies related to hypoxia. Application to 5023 SE].
    Devissaguet M
    Presse Med; 1983 Mar; 12(13):823-9. PubMed ID: 6220330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [First Forum on Updates on Cerebral Ischemia Pathology. Seville, 1-4 October 1987. Proceedings].
    Rev Med Interne; 1988 Feb; 9(1):1-72. PubMed ID: 3387701
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effects of 5023 SE on PaO2 at rest in elderly patients with cerebral impairment. A double-blind cross-over trial versus placebo].
    Memin Y
    Presse Med; 1983 Mar; 12(13):849-51. PubMed ID: 6220335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curative effect of an almitrine-raubasine combination in the postischemic syndrome following transient cerebral ischemia in dogs.
    Cahn R; Cahn J
    Pharmacology; 1988; 36(3):156-65. PubMed ID: 3368502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress in understanding the pathophysiology of cerebral ischemia: the almitrine-raubasine approach.
    Bentué-Ferrer D; Decombe R; Reymann JM; Schatz C; Allain H
    Clin Neuropharmacol; 1990; 13 Suppl 3():S9-25. PubMed ID: 2093421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathophysiology of postischemic hypoxia and cerebral protection: implications of the almitrine and raubasine combination.
    Chan P
    Eur Neurol; 1995; 35 Suppl 1():23-7. PubMed ID: 8529726
    [No Abstract]   [Full Text] [Related]  

  • 15. [Demonstration of the therapeutic activity of 5023 SE on intellectual and psychomotor efficacy in elderly impaired patients. Double-blind controlled study versus placebo].
    Berthaux P; Laforestrie R
    Presse Med; 1983 Mar; 12(13):852-5. PubMed ID: 6220336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ultrastructural study of acute ischemia at the peripheral level. Effects of 5023 SE].
    Delorme P
    Presse Med; 1983 Mar; 12(13):839-43. PubMed ID: 6220332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of the effects of almitrine, raubasine and 5023 SE on arterial oxygen desaturation during exercise].
    Sebban C; Berthaux P
    Presse Med; 1983 Mar; 12(13):847-8. PubMed ID: 6220334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stroke and functional rehabilitation: the Chinese experience.
    Li SW
    Eur Neurol; 1998; 39 Suppl 1():26-30. PubMed ID: 9516072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Duxil and cognitive deficiency in the elderly. Results of a 6-month controlled multicenter study].
    Poitrenaud J; Piette F; Malbezin M; Sebban C; Guez D
    Ann Med Interne (Paris); 1990; 141 Suppl 1():31-5. PubMed ID: 2082783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ultrastructural study of acute ischemia at the cerebral level. Effects of 5023 SE].
    Delorme P
    Presse Med; 1983 Mar; 12(13):830-8. PubMed ID: 6220331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.